Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2000 (Second Quarter of Fiscal Year 2001)
Business Overview: The Company manufactures and distributes dietary supplements and nutritional products. Operations include facilities in San Marcos, California, and Lugano, Switzerland. The Company is currently executing a cost containment program and diversifying its customer base following the loss of significant clients in the prior fiscal year.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2000 |
Six Months Ended Dec 31, 2000 |
Six Months Ended Dec 31, 1999 |
|---|---|---|---|
| Net Sales | $11.24 million | $21.46 million | $27.33 million |
| Gross Profit | $2.85 million (25% margin) | $4.86 million (23% margin) | $2.67 million (10% margin) |
| Net Earnings (Loss) | $0.44 million | $0.65 million | ($2.32 million) |
| EPS (Basic/Diluted) | $0.08 | $0.11 | ($0.40) |
| Cash and Equivalents | $0.99 million | Balance Sheet Data (Dec 31, 2000) | |
| Total Debt (Current + Long-term) | $7.42 million | ||
| Working Capital | $8.53 million |
Note: All figures in millions unless otherwise noted. Prior year six-month data included a $2.0 million inventory write-off.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 7% in the quarter and 21% in the six-month period compared to the prior year. This was primarily due to the loss of two major customers (NuSkin Enterprises and Bally Total Fitness), which accounted for $3.3 million in sales in the prior year's quarter.
- Profitability Improvement: The Company returned to profitability ($0.65 million net earnings for six months) compared to a $2.32 million loss in the prior year. This turnaround was driven by a $2.2 million increase in gross profit, largely due to the elimination of a $2.0 million inventory write-off recorded in the prior year and significant cost savings from bringing packaging operations in-house.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased by $1.0 million in the quarter and $2.2 million in the six-month period, attributed to a cost containment program, workforce reductions, and the termination of a facility lease obligation.
- Debt Restructuring: On December 20, 2000, the Company replaced an existing credit agreement with $9.35 million in new financing, including a $7.0 million working capital line of credit and a $1.6 million equipment term note.
Outlook, Risks, and Contingencies
Management Commentary and Outlook
Management expects operating results to fluctuate and cannot predict with assurance if profitability will be sustained. The Company is focusing on diversifying distribution channels, expanding Swiss manufacturing, and growing its direct-to-consumer "Dr. Cherry" brand to offset the loss of major customers. The cost containment program, including a 27% workforce reduction and in-house packaging, is intended to align expenses with current operating levels.
Material Risks and Contingencies
- Customer Concentration: Three major customers accounted for approximately 71% of net sales for the six months ended December 31, 2000. The loss of any single major customer could have a material adverse impact.
- Joint Venture Default: The Company's joint venture partner, FitnessAge, failed to meet payment obligations on a $750,000 loan (plus accrued interest) in February 2001. The Company has accelerated the loan maturity and intends to retain collateral (proprietary software and equity interests) in satisfaction of the debt. The outcome of this foreclosure is uncertain.
- Legal Proceedings: The Company is a defendant in a lawsuit filed by a former executive alleging damages in excess of $6 million. Management believes the claims are without merit but anticipates significant legal expenses. The Company is also a plaintiff in an antitrust lawsuit regarding vitamin manufacturers, having received $110,000 in settlements to date.
- Financing Covenants: The Company is subject to restrictive covenants regarding tangible net worth, leverage ratios, and minimum earnings. While compliant as of December 31, 2000, future non-compliance could result in a default.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top three customers, which represent over 70% of revenue.
- Joint Venture Recovery: Assess the commercial value of the collateral (software and equity) seized from FitnessAge following their default.
- Legal Exposure: Monitor the status of the $6 million lawsuit filed by the former President/CFO and the potential for significant legal costs or liability.
- Covenant Compliance: Confirm continued compliance with debt covenants, specifically minimum tangible net worth and earnings requirements, given the history of waivers.
- Inventory Valuation: Review inventory levels ($7.87 million) to ensure no further write-offs are necessary following the $2.0 million write-off in the prior year.